Literature DB >> 9230196

Normal polymorphism in the incomplete trinucleotide repeat of the arginine-rich protein gene.

E Evron1, P Cairns, N Halachmi, S A Ahrendt, A L Reed, D Sidransky.   

Abstract

The arginine-rich protein (ARP) gene was recently cloned and localized to human chromosome band 3p21. Recent reports have suggested that ARP is mutated in a high percentage of different human tumors. We amplified and sequenced the multiple arginine coding area of the ARP gene in primary head and neck, non-small cell lung, and renal cell cancers. We found a high frequency of genetic changes in this region, including a single base pair substitution and deletions of arginine repeats in primary tumors. However, these changes were always present in matched normal controls. Thus, the variations in the ARP trinucleotide repeat region represent normal polymorphisms rather than tumor-specific mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230196

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

Authors:  Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.

Authors:  Ada Piepoli; Annamaria Gentile; Maria Rosa Valvano; Daniela Barana; Cristina Oliani; Rosa Cotugno; Michele Quitadamo; Angelo Andriulli; Francesco Perri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

3.  Intracellular trafficking and secretion of mouse mesencephalic astrocyte-derived neurotrophic factor.

Authors:  Kentaro Oh-Hashi; Kensuke Tanaka; Hisashi Koga; Yoko Hirata; Kazutoshi Kiuchi
Journal:  Mol Cell Biochem       Date:  2011-11-27       Impact factor: 3.396

4.  Application of NanoBiT for Monitoring Dimerization of the Null Hong Kong Variant of α-1-Antitrypsin, NHK, in Living Cells.

Authors:  Junpei Norisada; Keito Fujimura; Fumimasa Amaya; Hiroki Kohno; Yoko Hirata; Kentaro Oh-Hashi
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

5.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Authors:  A T Ferguson; E Evron; C B Umbricht; T K Pandita; T A Chan; H Hermeking; J R Marks; A R Lambers; P A Futreal; M R Stampfer; S Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  Potential Role of MANF, an ER Stress Responsive Neurotrophic Factor, in Protecting Against Alcohol Neurotoxicity.

Authors:  Wen Wen; Hui Li; Jia Luo
Journal:  Mol Neurobiol       Date:  2022-03-07       Impact factor: 5.590

7.  Upregulation of mesencephalic astrocyte-derived neurotrophic factor in glial cells is associated with ischemia-induced glial activation.

Authors:  Yujun Shen; Aimin Sun; Yunhong Wang; Daqin Cha; Haiping Wang; Facai Wang; Lijie Feng; Shengyun Fang; Yuxian Shen
Journal:  J Neuroinflammation       Date:  2012-11-23       Impact factor: 8.322

8.  Spatiotemporal expression of MANF in the developing rat brain.

Authors:  Haiping Wang; Zunji Ke; Alexander Alimov; Mei Xu; Jacqueline A Frank; Shengyun Fang; Jia Luo
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  A Comparative Analysis of the Molecular Features of MANF and CDNF.

Authors:  Junpei Norisada; Yoko Hirata; Fumimasa Amaya; Kazutoshi Kiuchi; Kentaro Oh-hashi
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

10.  Transcriptional regulation of mouse mesencephalic astrocyte-derived neurotrophic factor in Neuro2a cells.

Authors:  Kentaro Oh-Hashi; Yoko Hirata; Kazutoshi Kiuchi
Journal:  Cell Mol Biol Lett       Date:  2013-07-17       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.